£10.4M
The financing was co-ordinated by WG Partners to support analytical platform expansion and new therapeutics programmes.
PrecisionLife
PrecisionLife develops AI-led drug discovery platforms for chronic disease.
£10.4MTotal raised
PrecisionLife is a techbio company that uses artificial intelligence to drive drug discovery and clinical development for chronic diseases. The firm operates globally with a focus on patient data analytics and precision medicine.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from PrecisionLife's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
Steve Gardner
CEO
Steve serves as chief executive of PrecisionLife and chairs the BioIndustry Association data, AI, and genomics advisory committee. He also holds advisory roles with Our Future Health UK and the Complex Disorders Alliance.
LinkedInSC
Sue Charles